Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,067 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,373
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +14.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (618)

clinicaltrialsPublishedShowing 51–100 of 352 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07749859	SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma	not yet recruiting	Phase 2	80	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	Aug 6, 2026	clinicaltrials
NCT07209215	ctDNA-Informed Management of Early-Stage Rectal Cancer(ULTIMATE)	not yet recruiting	Phase 2	200	University of California, DavisOTHER	1